503464-99-1

Basic information

• Product Name: 1-(2-Methoxy-5-trifluoromethylphenyl)ethanone
• Synonyms: 1-(2-Methoxy-5-trifluoromethylphenyl)ethanone;2'-Methoxy-5'-(trifluoromethyl;2'-Methoxy-5'-(trifluoromethyl)acetophenone, JRD, 97%;1-(2-Hydroxy-5-trifluoroMethyl-phenyl)-ethanone;Ethanone, 1-[2-methoxy-5-(trifluoromethyl)phenyl]-;1-(5-(trifluoromethyl)-2-methoxyphenyl)ethanone;1-(2-Methoxy-5-trifluoromethylphenyl)
• CAS NO: 503464-99-1
• Molecular Formula: C₁₀H₉F₃O₂
• Molecular Weight: 218.173
• Mol File: 503464-99-1.mol

Chemical Properties

• Melting Point: 45-47℃
• Boiling Point: 230.1±40.0 °C(Predicted)
• Appearance: /
• Density: 1.222±0.06 g/cm3(Predicted)
• Solubility: Slightly soluble.
• CAS DataBase Reference: 1-(2-Methoxy-5-trifluoromethylphenyl)ethanone(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-Methoxy-5-trifluoromethylphenyl)ethanone(503464-99-1)
• EPA Substance Registry System: 1-(2-Methoxy-5-trifluoromethylphenyl)ethanone(503464-99-1)

Safety Data

• Hazardous Substances Data: 503464-99-1(Hazardous Substances Data)

Usage

Uses

1. Used in Pharmaceutical Industry:
1-(2-Methoxy-5-trifluoromethylphenyl)ethanone is used as an intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
2. Used in Synthesis and Evaluation of Disubstituted N1and N3-Imidazolidin-2-ones:
1-(2-Methoxy-5-trifluoromethylphenyl)ethanone is used as a key component in the synthesis and evaluation of disubstituted N1and N3-Imidazolidin-2-ones. These compounds have been identified as potential immunosuppressive agents, which can be beneficial in the treatment of autoimmune diseases and organ transplantation.
3. Used in Chemical Research:
Due to its unique structure and properties, 1-(2-Methoxy-5-trifluoromethylphenyl)ethanone is also used in chemical research for studying various reaction mechanisms and exploring new synthetic pathways. This can lead to the discovery of novel compounds with potential applications in different industries.
4. Used in Material Science:
1-(2-Methoxy-5-trifluoromethylphenyl)ethanone may also find applications in material science, where its unique properties can be utilized in the development of new materials with specific characteristics, such as improved stability, reactivity, or selectivity.

Upstream product

• 402-52-8 methyl 4-(trifluoromethyl)phenyl ether 
• 108-24-7 acetic anhydride 
• 402-45-9 4-hydroxybenzotrifluoride 

Downstream Products

• 67589-15-5 1-(2-hydroxy-5-(trifluoromethyl)phenyl)ethan-1-one 
• 1345731-86-3 tert-butyl {(R)-2-[2-acetyl-4-(trifluoromethyl)phenoxy]-1-methylethyl}carbamate 
• 1345731-58-9 (3R,5S)-4-(4-chlorobenzoyl)-3,5-dimethyl-7-(trifluoromethyl)-2,3,4,5-tetrahydro-1,4-benzoxazepine 
• 1235407-24-5 (E)-3-(dimethylamino)-1-(2-hydroxy-5-(trifluoromethyl)phenyl)prop-2-en-1-one 
• 1235407-23-4 tert-butyl 3-[5-(5-trifluoromethyl-2-hydroxyphenyl)-1H-pyrazol-1-yl]azetidine-1-carboxylate 
• 1354819-31-0 tert-butyl 3-{5-[5-trifluoromethyl-2-(2-chloro-4-{[(2,4-dimethoxybenzyl)(1,3,4-thiadiazol-5-yl)amino]sulfonyl}-5-fluorophenoxy)phenyl]-1H-pyrazol-1-yl}azetidine-1-carboxylate 
• 1354818-96-4 4-[2-(1-azetidin-3-yl-1H-pyrazol-5-yl)-5-chloro-2-fluoro-4-(trifluoromethyl)phenoxy]-N-1,3,4-thiadiazol-5-yl benzenesulfonamide 
• 1354818-97-5 5-chloro-2-fluoro-4-{4-trifluoromethyl-2-[1-(1-methylazetidin-3-yl)-1H-pyrazol-5-yl]phenoxy}-N-1,3,4-thiadiazol-ylbenzenesulfonamide 

Relevant articles and documents

Substituted Pyrrolidines and Methods of Use

The invention discloses compounds of Formula (I) wherein R1, R2, R2A, R3, R3A, R4, and R5 are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.

Discovery of potent selective orally active benzoxazepine-based orexin-2 receptor antagonists

During our efforts to identify a series of potent, selective, orally active human Orexin-2 Receptor (OX2R) antagonists, we elucidated structure-activity relationship (SAR) on the 7-position of a benzoxazepine scaffold by utilizing Hammett rp and Hansch-Fu

NOVEL OXIME DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS

The present invention provides new oxime derivatives of the general formula (I), pharmaceutical compositions containing them and their use for the treatment and/or prophylaxis of conditions associated with altered glutamatergic signalling and/or functions

THIAZOLE COMPOUNDS AS ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE

Disclosed are compounds of formula (I) wherein R1 and R2 are independently selected from hydrogen, halo, C1-4alkyl, C1-4alkoxy, CF3 and OCF3; -Y- represents formula (IA) R3 represents hydrogen, fluoro, chloro or C1-4alkyl; R4a and R4b each independently represent hydrogen, C1-4alkyl, C1-4alkoxy, CF3 or halo; and R5 represents a group Z-X; wherein Z is absent or represents (CH2)2 or O; and X represents formula (IB) wherein: J and L both represent CH, or one of J and L represents CH and the other represents N; when both J and L represent CH, R6 represents hydrogen, halo, CF3, C1-4alkyl or C1-4alkoxy in a meta or ortho position relative to the R7 substituent and R7 represents hydrogen, halo, CF3, OCF3, C1-4alkyl, C1-4alkoxy, CH2OH, CN, CONR8R9 or CO2H; or when one of J or L represents N, R6 represents hydrogen or halo in a meta or ortho position relative to the R7 substituent and R7 represents hydrogen, halo, CF3, C1-4alkyl, C1-4alkoxy, CH2OH, CN, CONR8R9 or CO2H; and R8 and R9 are independently selected from hydrogen and C1-4alkyl; or salts thereof which activate soluble guanylate cyclase (sGC), pharmaceutical compositions containing them, their use in medicine, and processes for their preparation.

Process for producing 4-substituted benzopyran derivatives

The present invention relates to a first process for producing a 2,2-bis(fluoromethyl)-6-(perfluoroalkyl)-2H-1-benzopyran-4-carboxylic acid. The first process includes the steps of (a) reacting a 2,2-bis(fluoromethyl)-6-(perfluoroalkyl)-2H-1-benzopyran-4-